IMP-3 is a novel progression marker in malignant melanoma.
Pryor JG; Bourne PA; Yang Q; Spaulding BO; Scott GA; Xu H; Modern Pathology: An Official Journal Of The United States And Canadian Academy Of Pathology, Inc, 2008, vol. 21, issue 4, p 431, ISSN 08933952. ISBN 08933952.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef